Cargando…

Association between metabolic syndrome and pelvic organ prolapse severity

INTRODUCTION AND HYPOTHESIS: As in the case of cardiovascular and metabolic diseases, the prevalence of pelvic organ prolapse (POP) has been rising with the increasing proportion of elderly women in the population. The purpose of the present cross-sectional study was to evaluate the components of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogowski, A., Bienkowski, P., Tarwacki, D., Dziech, E., Samochowiec, J., Jerzak, M., Baranowski, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371825/
https://www.ncbi.nlm.nih.gov/pubmed/25047898
http://dx.doi.org/10.1007/s00192-014-2468-9
_version_ 1782363105124155392
author Rogowski, A.
Bienkowski, P.
Tarwacki, D.
Dziech, E.
Samochowiec, J.
Jerzak, M.
Baranowski, W.
author_facet Rogowski, A.
Bienkowski, P.
Tarwacki, D.
Dziech, E.
Samochowiec, J.
Jerzak, M.
Baranowski, W.
author_sort Rogowski, A.
collection PubMed
description INTRODUCTION AND HYPOTHESIS: As in the case of cardiovascular and metabolic diseases, the prevalence of pelvic organ prolapse (POP) has been rising with the increasing proportion of elderly women in the population. The purpose of the present cross-sectional study was to evaluate the components of metabolic syndrome (MS) in urogynecological patients with a variable POP severity. METHODS: The MS risk factors (elevated waist circumference, elevated triglycerides, decreased high-density lipoprotein cholesterol, elevated blood pressure, hyperglycemia) were assessed in 100 women who were referred to our urogynecological center with pelvic floor disorders (PFD). POP was evaluated with the Pelvic Organ Prolapse Quantification system (POP-Q). RESULTS: The χ (2) test revealed that the diagnosis of MS and the presence of elevated triglycerides increased with the overall POP-Q stage. The other MS risk factors were not significantly associated with the overall POP-Q stage. MS and elevated triglycerides were predictors of the POP-Q stage ≥III [odds ratio (OR) 3.5, 95 % confidence interval (CI) 1.5–8.2 for MS and OR 3.4, 95 % CI 1.4–8.2 for elevated triglycerides, p < 0.01]. CONCLUSIONS: The diagnosis of MS and the presence of elevated triglycerides may be associated with the severity of POP in urogynecological patients. Longitudinal studies are required to assess whether the MS risk factors might predict the progression of POP and whether elimination of the risk factors might improve the prognosis in POP patients.
format Online
Article
Text
id pubmed-4371825
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-43718252015-03-27 Association between metabolic syndrome and pelvic organ prolapse severity Rogowski, A. Bienkowski, P. Tarwacki, D. Dziech, E. Samochowiec, J. Jerzak, M. Baranowski, W. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: As in the case of cardiovascular and metabolic diseases, the prevalence of pelvic organ prolapse (POP) has been rising with the increasing proportion of elderly women in the population. The purpose of the present cross-sectional study was to evaluate the components of metabolic syndrome (MS) in urogynecological patients with a variable POP severity. METHODS: The MS risk factors (elevated waist circumference, elevated triglycerides, decreased high-density lipoprotein cholesterol, elevated blood pressure, hyperglycemia) were assessed in 100 women who were referred to our urogynecological center with pelvic floor disorders (PFD). POP was evaluated with the Pelvic Organ Prolapse Quantification system (POP-Q). RESULTS: The χ (2) test revealed that the diagnosis of MS and the presence of elevated triglycerides increased with the overall POP-Q stage. The other MS risk factors were not significantly associated with the overall POP-Q stage. MS and elevated triglycerides were predictors of the POP-Q stage ≥III [odds ratio (OR) 3.5, 95 % confidence interval (CI) 1.5–8.2 for MS and OR 3.4, 95 % CI 1.4–8.2 for elevated triglycerides, p < 0.01]. CONCLUSIONS: The diagnosis of MS and the presence of elevated triglycerides may be associated with the severity of POP in urogynecological patients. Longitudinal studies are required to assess whether the MS risk factors might predict the progression of POP and whether elimination of the risk factors might improve the prognosis in POP patients. Springer London 2014-07-22 2015 /pmc/articles/PMC4371825/ /pubmed/25047898 http://dx.doi.org/10.1007/s00192-014-2468-9 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Rogowski, A.
Bienkowski, P.
Tarwacki, D.
Dziech, E.
Samochowiec, J.
Jerzak, M.
Baranowski, W.
Association between metabolic syndrome and pelvic organ prolapse severity
title Association between metabolic syndrome and pelvic organ prolapse severity
title_full Association between metabolic syndrome and pelvic organ prolapse severity
title_fullStr Association between metabolic syndrome and pelvic organ prolapse severity
title_full_unstemmed Association between metabolic syndrome and pelvic organ prolapse severity
title_short Association between metabolic syndrome and pelvic organ prolapse severity
title_sort association between metabolic syndrome and pelvic organ prolapse severity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371825/
https://www.ncbi.nlm.nih.gov/pubmed/25047898
http://dx.doi.org/10.1007/s00192-014-2468-9
work_keys_str_mv AT rogowskia associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT bienkowskip associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT tarwackid associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT dzieche associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT samochowiecj associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT jerzakm associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity
AT baranowskiw associationbetweenmetabolicsyndromeandpelvicorganprolapseseverity